![Dario Eklund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dario Eklund
Chief Executive Officer at
SANTHERA PHARMACEUTICALS HOLDING AG
Net worth: 2 M $ as of 30/05/2026
Profile
Dario Eklund is currently the Chief Executive Officer at Santhera Pharmaceuticals Holding AG since 2019.
Formerly, the roles included Commercial Director at Novartis AG from 1994 to 2002, General Manager-Switzerland at Sanofi from 2002 to 2004, VP-Business Development & Gintuit Business Unit at Organogenesis, Inc. from 2004 to 2014, Head-Global Business Operations at Vifor Pharma Management AG from 2014 to 2019, Chief Commercial Officer at Corden Pharma Fribourg SA from 2017 to 2019, Member-Supervisory Board at Vifor Fresenius Medical Care Renal Pharma Ltd. from 2017 to 2019, and General Manager-Switzerland Region at Aventis Pharma AG.
Education includes graduate studies at Hanken Svenska Handelshögskolan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/12/2024 | 110,526 ( 0.74% ) | 2 M $ | 30/05/2026 |
Dario Eklund active positions
| Companies | Position | Start |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Chief Executive Officer | 30/11/2019 |
Former positions of Dario Eklund
| Companies | Position | End |
|---|---|---|
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Corporate Officer/Principal | 29/09/2019 |
| VIFOR PHARMA | Corporate Officer/Principal | 29/09/2019 |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Director/Board Member | 31/12/2018 |
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Designs and manufactures regenerative medical products | Corporate Officer/Principal | 31/12/2013 |
| SANOFI | Corporate Officer/Principal | 31/12/2003 |
Training of Dario Eklund
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Designs and manufactures regenerative medical products | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services | Health Technology |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Aventis Pharma AG | |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Health Technology |
Hanken Svenska Handelshögskolan
 Hanken Svenska Handelshögskolan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vifor Fresenius Medical Care Renal Pharma Ltd.
Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Health Technology |
- Stock Market
- Insiders
- Dario Eklund
